Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 31 May 24 S-1/A IPO registration (amended)
- 10 May 24 S-1/A IPO registration (amended)
-
19 Apr 24 S-1 IPO registration
NDRA similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders’ of
ENDRA Life Sciences Inc.
We hereby consent to the incorporation by reference in this Registration Statement on Form S-1 of our report dated March 28, 2024 on the consolidated financial statements of ENDRA Life Sciences Inc. and its subsidiaries, and the reference to our firm under the heading “Experts” in the prospectus included in this Registration Statement on Form S-1. Our report includes an explanatory paragraph expressing substantial doubt regarding the Company’s ability to continue as a going concern.
/s/ RBSM LLP
New York, New York
April 19, 2024